The economic burden of schizophrenia is a significant issue, with estimated annual costs in the united states reportedly exceeding $350 billion, although the exact figure is uncertain, with some estimates ranging up to $367 billion. The condition is said to impose a substantial societal burden, encompassing both direct and indirect costs. The economic impact of schizophrenia is being studied and quantified in various research efforts, including a recent study that provides a state-by-state breakdown of the costs.